McCanlies EC - Search Results

1

HLA-DPB1 and chronic beryllium disease: a HuGE review.

McCanlies EC, Kreiss K, Andrew M, Weston A. McCanlies EC, et al. Am J Epidemiol. 2003 Mar 1;157(5):388-98. doi: 10.1093/aje/kwg001. Am J Epidemiol. 2003. PMID: 12615603 Review.

2

DNA sequence variants of p53: cancer and aging.

Sun Y, Keshava C, Sharp DS, Weston A, McCanlies EC. Sun Y, et al. Among authors: mccanlies ec. Am J Hum Genet. 1999 Dec;65(6):1779-82. doi: 10.1086/302650. Am J Hum Genet. 1999. PMID: 10577934 Free PMC article. No abstract available.

3

Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States.

Keshava C, McCanlies EC, Keshava N, Wolff MS, Weston A. Keshava C, et al. Among authors: mccanlies ec. Cancer Lett. 2001 Nov 8;173(1):37-41. doi: 10.1016/s0304-3835(01)00671-1. Cancer Lett. 2001. PMID: 11578807

4

Waf-1 (p21) and p53 polymorphisms in breast cancer.

Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A. Keshava C, et al. Among authors: mccanlies ec. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):127-30. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815410

5

Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.

Weston A, Ensey J, Kreiss K, Keshava C, McCanlies E. Weston A, et al. Am J Ind Med. 2002 Jun;41(6):457-65. doi: 10.1002/ajim.10072. Am J Ind Med. 2002. PMID: 12173370

6

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.

McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A. McCanlies EC, et al. Am J Ind Med. 2004 Aug;46(2):95-103. doi: 10.1002/ajim.20045. Am J Ind Med. 2004. PMID: 15273960

7

CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review.

Keshava C, McCanlies EC, Weston A. Keshava C, et al. Among authors: mccanlies ec. Am J Epidemiol. 2004 Nov 1;160(9):825-41. doi: 10.1093/aje/kwh294. Am J Epidemiol. 2004. PMID: 15496535 Review.

8

Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.

Keshava C, Divi RL, Whipkey DL, Frye BL, McCanlies E, Kuo M, Poirier MC, Weston A. Keshava C, et al. Cancer Lett. 2005 Apr 28;221(2):213-24. doi: 10.1016/j.canlet.2004.08.038. Cancer Lett. 2005. PMID: 15808407

9

Immunogenetic factors in beryllium sensitization and chronic beryllium disease.

Weston A, Snyder J, McCanlies EC, Schuler CR, Andrew ME, Kreiss K, Demchuk E. Weston A, et al. Among authors: mccanlies ec. Mutat Res. 2005 Dec 30;592(1-2):68-78. doi: 10.1016/j.mrfmmm.2005.06.005. Epub 2005 Jul 27. Mutat Res. 2005. PMID: 16054169 Review.

10

TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.

McCanlies EC, Schuler CR, Kreiss K, Frye BL, Ensey JS, Weston A. McCanlies EC, et al. J Occup Environ Med. 2007 Apr;49(4):446-52. doi: 10.1097/JOM.0b013e31803b9499. J Occup Environ Med. 2007. PMID: 17426528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page